Antitumor and antimicrobial activity of exometabolites of Black Sea actinobacteria

Ivanytsia, V. O.; Gudzenko, T. V.; Gorshkova, O. H.; Korotaieva, N. V.; Strashnova, I. V.; Shtenikov, M. D.; Lisyutin, G. V.

doi:10.7124/bc.000AD4

Biopolym. Cell. 2024; 40(3):233-233.

http://dx.doi.org/10.7124/bc.000AD4

Chronicle and Information

Antitumor and antimicrobial activity of exometabolites of Black Sea actinobacteria

1Ivanytsia V. O., 1Gudzenko T. V., 1Gorshkova O. H., 1Korotaieva N. V., 1Strashnova I. V., 1Shtenikov M. D., 1Lisyutin G. V.

Odesa National I. I. Mechnikov University
2, Dvoryanska Str., Odesa, Ukraine, 65082

Abstract

Aim. The aim is to determine the biotechnological potential of marine actinobacteria in order to assess the prospects for their use as producers of antibiotics and antitumour compounds in the biotechnology of new drugs. Conclusions. The Black Sea strains of actinobacteria Lim9.2 and Lim10 are promising producers of antitumor compounds and antibiotics and can be recommended for use in the biotechnology of new drugs.

Keywords: marine streptomycetes, exometabolites, antimicrobial and cytotoxic activity, tumour cell cultures

Full text: (PDF, in English)

References

[1] Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-63.

[2] Ivanytsia VO Shtenikov MD, Strashnova IV, Korotaieva NV, Tytarenko NV, Gudzenko TV, Vasylieva NY, Gorshkova OG, Lisiutin GV, Potapenko KS, Andriushchenko OV, Chaban MM. Characteristics of marine strain Streptomyces sp. with antimicrobial and cytotoxic activity. Biosyst Divers. 2023; 31(4):43-51.

[3] Paulus C, Rebets Y, Tokovenko B, Nadmid S, Terekhova LP, Myronovskyi M, Zotchev SB, Rückert C, Braig S, Zahler S, Kalinowski J, Luzhetskyy A. New natural products identified by combined genomics-metabolomics profiling of marine Streptomyces sp. MP131-18. Sci Rep. 2017; 7:42382.